Evaluation of the Effect of Melissa Officinalis L ( Lemon Balm) Capsule on Cognitive Impairment in Depressed Patients Treated With ECT
Phase 3
Recruiting
- Conditions
- Major Depression , ECT.Mental disorder, Not Otherwise Specified
- Registration Number
- IRCT20180613040083N1
- Lead Sponsor
- Shahre-kord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
The age range of patients is 18-65 years.
Their Major Depressive Disorder has been confirmed by a psychiatrist
The patient has no history of allergy to The mint family.
Lack of physical illness leading to Cognitive Impairment such as Head Trauma, Dementia, Retardation - Mental Retardation And EpilepsyPatients
Receiving SSRIs (according to a psychiatrist).
Exclusion Criteria
Patients who have other Mental Misorders in addition to Depression..
Reluctance to continue cooperation before The end of the project
Occurrence of stressful events affecting The patient's mood during the implementation of The plan
Use of other Antidepressants Drugs(except SSRIs)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitive Disorders Score in Cognitive Status Assessment Questionnaire (MMSE Questionnaire). Timepoint: Measurement of Cognitive Disorders before intervention and one month after consumption of Lemon Balm Capsules. Method of measurement: Cognitive Status Assessment Questionnaire (MMSE Questionnaire).
- Secondary Outcome Measures
Name Time Method